AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,151,000 | -17.6% | 49,277 | -20.0% | 0.02% | -18.2% |
| Q1 2018 | $5,037,000 | +296.9% | 61,600 | +223.9% | 0.02% | +214.3% |
| Q3 2017 | $1,269,000 | -71.1% | 19,020 | -77.7% | 0.01% | -73.1% |
| Q2 2017 | $4,396,000 | +1141.8% | 85,431 | +882.0% | 0.03% | +1200.0% |
| Q1 2016 | $354,000 | -24.0% | 8,700 | +21.1% | 0.00% | 0.0% |
| Q4 2015 | $466,000 | -70.0% | 7,187 | -67.3% | 0.00% | -75.0% |
| Q3 2015 | $1,551,000 | -74.3% | 21,970 | -59.5% | 0.01% | -77.8% |
| Q2 2015 | $6,035,000 | +1043.0% | 54,300 | +869.6% | 0.04% | +800.0% |
| Q1 2015 | $528,000 | -64.0% | 5,600 | -57.3% | 0.00% | -63.6% |
| Q4 2014 | $1,467,000 | – | 13,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |